{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:49:37Z","timestamp":1780393777317,"version":"3.54.1"},"reference-count":35,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,2,2]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Compression is the mainstay of treatment for venous leg ulcers (VLUs) and there are few effective adjuvant treatments. There is only observational evidence supporting the use of hypochlorous acid (HOCl) as a topical wound solution on VLU and some limited randomised evidence for the effect of a prescribed regimen of exercise.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>The Factorial4VLU trial is a pragmatic, blinded, factorial randomised controlled trial, with 380 participants receiving either a prescribed exercise regimen compared with usual care and either active HOCl wound solution or placebo wound solution at each dressing change for up to 24 weeks. All participants will receive compression therapy. The primary outcome is the proportion of participants with healed VLU at 12 weeks after randomisation as adjudicated by blinded review of ulcer photographs. Secondary outcomes are proportion healed at 24 weeks, time to healing, estimated change in ulcer area, change in 2-Minute Walk Test, change in health-related quality of life, incidence of infection and incidence of all-cause adverse events. If either of the interventions shows a statistically significant positive difference on healing outcomes, cost-effectiveness will be modelled using a health service perspective.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>The Factorial4VLU trial received ethical approval from the Northern B Health and Disability Ethics Committee. We plan to publish the results within 1\u2009year of trial completion and will include the results on the trial registration page.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration numbers<\/jats:title><jats:p>Australia and New Zealand Clinical Trials Register (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.anzctr.org.au\">http:\/\/www.anzctr.org.au<\/jats:ext-link>) (ACTRN12620000116921); Universal Trial Number (WHO) (U1111-1236-2997).<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2020-043420","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T16:35:45Z","timestamp":1613666145000},"page":"e043420","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU)"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8484-3771","authenticated-orcid":false,"given":"Andrew","family":"Jull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Wadham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-2930","authenticated-orcid":false,"given":"Chris","family":"Bullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Parag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G M","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Laking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos","family":"Klonizakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"O\"Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"2024101905111769000_11.2.e043420.1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6059"},{"key":"2024101905111769000_11.2.e043420.2","doi-asserted-by":"crossref","first-page":"j5157","DOI":"10.1136\/bmj.j5157","article-title":"Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU)","volume":"358","author":"Jull","year":"2017","journal-title":"BMJ"},{"key":"2024101905111769000_11.2.e043420.3","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1801214","article-title":"A randomized trial of early endovenous ablation in venous ulceration","volume":"378","author":"Gohel","year":"2018","journal-title":"N Engl J Med"},{"key":"2024101905111769000_11.2.e043420.4","article-title":"Pentoxifylline for treating venous leg ulcers","author":"Jull","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2024101905111769000_11.2.e043420.5","first-page":"9","article-title":"Usual care versus guideline recommendations for venous ulcer management in New Zealand","volume":"122","author":"Jull","year":"2009","journal-title":"NZ Med J"},{"key":"2024101905111769000_11.2.e043420.6","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.14"},{"key":"2024101905111769000_11.2.e043420.7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.1999.00993.x"},{"key":"2024101905111769000_11.2.e043420.8","doi-asserted-by":"publisher","DOI":"10.1016\/0741-5214(94)90223-2"},{"key":"2024101905111769000_11.2.e043420.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2006.11.032"},{"key":"2024101905111769000_11.2.e043420.10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamadermatol.2018.3281","article-title":"Prescribed exercise with compression vs compression alone in treating patients with venous leg ulcers: a systematic review and meta-analysis","volume":"154","author":"Jull","year":"2018","journal-title":"JAMA Dermatol"},{"key":"2024101905111769000_11.2.e043420.11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/iwj.12571","article-title":"Evaluating the effectiveness of a self-management exercise intervention on wound healing, functional ability and health-related quality of life outcomes in adults with venous leg ulcers: a randomised controlled trial","volume":"14","author":"O\"Brien","year":"2017","journal-title":"Int Wound J"},{"key":"2024101905111769000_11.2.e043420.12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/bjd.16089","article-title":"Supervised exercise training as an adjunct therapy for venous leg ulcers: a randomized controlled feasibility trial","volume":"178","author":"Klonizakis","year":"2018","journal-title":"Br J Dermatol"},{"key":"2024101905111769000_11.2.e043420.13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/iwj.12933","article-title":"Exercise fidelity and progression in a supervised exercise programme for adults with venous leg ulcers","volume":"15","author":"Klonizakis","year":"2018","journal-title":"Int Wound J"},{"key":"2024101905111769000_11.2.e043420.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2012.00836.x"},{"key":"2024101905111769000_11.2.e043420.15","first-page":"326","article-title":"Efficacy and safety of oxum in treatment of the venous ulcer","volume":"106","author":"Dharap","year":"2008","journal-title":"J Indian Med Assoc"},{"key":"2024101905111769000_11.2.e043420.16","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.ASW.0000383198.35815.a2","article-title":"Evaluation of Vashe wound therapy in the clinical management of patients with chronic wounds","volume":"23","author":"Niezgoda","year":"2010","journal-title":"Adv Skin Wound Care"},{"key":"2024101905111769000_11.2.e043420.17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12968\/jowc.2006.15.1.26861","article-title":"Evaluation of hypochlorous acid washes in the treatment of chronic venous leg ulcers","volume":"15","author":"Selkon","year":"2006","journal-title":"J Wound Care"},{"key":"2024101905111769000_11.2.e043420.18","doi-asserted-by":"publisher","DOI":"10.1177\/1534734610361945"},{"key":"2024101905111769000_11.2.e043420.19","first-page":"151","article-title":"Comparison of super-oxidized solution versus povidine iodine in management of infected diabetic ulcers: our experience","volume":"3","author":"Prabhakar","year":"2016","journal-title":"Int Arch Integr Med"},{"key":"2024101905111769000_11.2.e043420.20","first-page":"32","article-title":"Effects of hypochlorous acid solutions on venous leg ulcers (VLU): experience with 1249 VLUs in 897 patients","volume":"6","author":"Bongiovanni","year":"2014","journal-title":"J Am Coll Clin Wound Spec"},{"key":"2024101905111769000_11.2.e043420.21","first-page":"2","article-title":"Expert recommendations for the use of hypochlorous solution: science and clinical application","volume":"61","author":"Armstrong","year":"2015","journal-title":"Ostomy Wound Manage"},{"key":"2024101905111769000_11.2.e043420.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00379-X"},{"key":"2024101905111769000_11.2.e043420.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036476"},{"key":"2024101905111769000_11.2.e043420.24","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2009.18.12.45606"},{"key":"2024101905111769000_11.2.e043420.25","unstructured":"Food and Drug Administration . Guidance for industry chronic cutaneous ulcer and burn wounds \u2014 developing products for treatment. Rockville, Maryland: Food and Drug Administration, 2006."},{"key":"2024101905111769000_11.2.e043420.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e1119"},{"key":"2024101905111769000_11.2.e043420.27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1445-2197.1991.tb00169.x","article-title":"Measurement of the healing of venous ulcers","volume":"61","author":"Stacey","year":"1991","journal-title":"Aust N Z J Surg"},{"key":"2024101905111769000_11.2.e043420.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00109-7"},{"key":"2024101905111769000_11.2.e043420.29","doi-asserted-by":"publisher","DOI":"10.3109\/07853890109002087"},{"key":"2024101905111769000_11.2.e043420.30","doi-asserted-by":"publisher","DOI":"10.1177\/026835550101600104"},{"key":"2024101905111769000_11.2.e043420.31","doi-asserted-by":"publisher","DOI":"10.3138\/physio.61.2.78"},{"key":"2024101905111769000_11.2.e043420.32","unstructured":"World Health Organization Uppsala Monitoring Centre . The use of the WHO-UMC system for standardised case causality assessment, 2013. Available: https:\/\/www.who.int\/publications\/m\/item\/WHO-causality-assessment [Accessed 15 February 2021]."},{"key":"2024101905111769000_11.2.e043420.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2024101905111769000_11.2.e043420.34","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-10-200411160-00009"},{"key":"2024101905111769000_11.2.e043420.35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jtv.2019.09.005","article-title":"Adverse event reporting and trial registration in venous leg ulcer trials published since the 2001 consort statement revision: a systematic review","volume":"29","author":"Jull","year":"2020","journal-title":"J Tissue Viability"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-043420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T12:14:02Z","timestamp":1729340042000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-043420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,18]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/bmjopen-2020-043420"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-043420","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}